In contrast, in an investigation of patients with hypopharyngeal cancer, radiotherapy (RT) was found to regulate programmed cell death ligand 1 (PD-L1) by upregulating GLUT1 expression, thereby promoting CD8+ T cell proliferation and regulating immune competence [46]. The gene discussed is CD274; the disease is hypopharynx cancer.